World's Largest Chinese Whisper Chain for Lymphoma

746 people from around the world made history today by uniting to break the Guinness World Record for the largest "Chinese whisper" chain - a record that previously stood at 718 people. With the aim of raising awareness of lymphoma, participants from 59 countries stood side-by-side to pass the message that "there is new hope for lymphoma patients". The record coincided with the 9th International Conference of Malignant Lymphoma (ICML) being held this week in Lugano, Switzerland.



Adam Morris, an ex-pro footballer and non-Hodgkin's lymphoma survivor who participated in the event, said, "I am privileged to have been part of this historical event. I hope my contribution and that of the other participants raises awareness of this disease and provides new hope for the management of lymphoma. If, as a result of this event, we help reach the hundreds of thousands of lymphoma patients to let them know that there are treatments that really work, we will have achieved our goal." News Release

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap